Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × MCRC × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1210 Neoplasms 954 Prostatic Neoplasms 644 Lung Neoplasms 517 Colorectal Neoplasms 497 Carcinoma, Non-Small-Cell Lung 464 Carcinoma, Hepatocellular 354 Pancreatic Neoplasms 351 Leukemia, Myeloid, Acute 322 Stomach Neoplasms 302 Multiple Myeloma 270 Ovarian Neoplasms 254 Brain Neoplasms 252 Head and Neck Neoplasms 243 Neoplasm Metastasis 226 Precursor Cell Lymphoblastic Leukemia-Lymphoma 224 Rectal Neoplasms 222 Esophageal Neoplasms 221 Uterine Cervical Neoplasms 215 Melanoma 205 Recurrence 196 Squamous Cell Carcinoma of Head and Neck 185 Glioblastoma 183 Lymphoma 182 Sarcoma 179 Urinary Bladder Neoplasms 172 Colonic Neoplasms 169 Glioma 162 Hematologic Neoplasms 153 Triple Negative Breast Neoplasms 152

Interventions

tislelizumab 1 regorafenib 1 Trace amine-associated receptor 1 1 Thymalfasin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06829355 2025-02-17

THYMI

Beijing Friendship Hospital

Phase 2 Recruiting

MCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡